Tumour-associated and non-tumour-associated microbiota in colorectal cancer

Gut

Volumn 66, Issue 4, 2017, Pages 633-643

  Flemer, Burkhardt ^a,b   Lynch, Denise B ^a,b   Brown, Jillian M R ^a,b   Jeffery, Ian B ^a,b   Ryan, Feargal J ^a,b   Claesson, Marcus J ^a,b   O'Riordain, Micheal ^c   Shanahan, Fergus ^a,b   O'Toole, Paul W ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c MERCY UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPLICON; ARTICLE; BACTERIAL GENE; BACTEROIDETES; CANCER SURGERY; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FECES ANALYSIS; FIRMICUTES; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INTESTINE BIOPSY; INTESTINE FLORA; MAJOR CLINICAL STUDY; POPULATION ABUNDANCE; PREVOTELLA; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; RNA SEQUENCE; ADULT; AGED; CASE CONTROL STUDY; COLON; COLON POLYP; COLON TUMOR; FECES; FEMALE; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; RECTUM TUMOR; VERY ELDERLY;

BACTERIAL ANTIGEN; CCL20 PROTEIN, HUMAN; CXCL1 CHEMOKINE; CXCL1 PROTEIN, HUMAN; IL17A PROTEIN, HUMAN; INTERLEUKIN 17; INTERLEUKIN 23; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA 16S; SERPINE1 PROTEIN, HUMAN;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; BACTEROIDETES; CASE-CONTROL STUDIES; CHEMOKINE CCL20; CHEMOKINE CXCL1; COLON; COLONIC NEOPLASMS; COLONIC POLYPS; FECES; FEMALE; FIRMICUTES; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION; HUMANS; INTERLEUKIN-17; INTERLEUKIN-23; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREVOTELLA; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; RNA, RIBOSOMAL, 16S;

EID: 84964320754     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2015-309595     Document Type: Article

References (37)

1. Burt RW. Colon cancer screening. Gastroenterology 2000;119:837-53.
2. Haggar FA, Boushey RP. Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors. Clin Colon Rectal Surg 2009;22:191-7.
3. Abreu MT, Peek RM Jr. Gastrointestinal malignancy and the microbiome. Gastroenterology, the gut microbiome in health and disease. Gastroenterology 2014;146:1534-1546.e3.
4. Sears CL, Garrett WS. Microbes, microbiota, and colon cancer. Cell Host Microbe 2014;15:317-28.
5. Wu S, Rhee KJ, Albesiano E, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17T cell responses. Nat Med 2009;15:1016-22.
6. Arthur JC, Perez-Chanona E, Mühlbauer M, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012;338:120-3.
7. Castellarin M, Warren RL, Freeman JD, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012;22:299-306.
8. Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumour-immune microenvironment. Cell Host Microbe 2013;14:207-15.
9. Tosolini M, Kirilovsky A, Mlecnik B, et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer. Cancer Res 2011;71:1263-71.
10. Zackular JP, Rogers MAM, Ruffin MT, et al. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res (Phila) 2014;7:1112-21.
11. Zeller G, Tap J, Voigt AY, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol 2014;10:766.
12. Yu J, Feng Q, Wong SH, et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut Published Online First: 13 Oct 2015. doi:10.1136/gutjnl-2015-309800
13. Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012;488:178-84.
14. Klindworth A, Pruesse E, Schweer T, et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res 2013;41:e1.
15. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010;7:335-6.
16. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J 2011;17:10-12.
17. Magoč T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 2011;27:2957-63.
18. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010;26:2460-1.
19. Haas BJ, Gevers D, Earl AM, et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res 2011;21:494-504.
20. Schloss PD, Westcott SL, Ryabin T, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 2009;75:7537-41.
21. Kostic AD, Gevers D, Pedamallu CS, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012;22:292-8.
22. Schloss PD, Gevers D, Westcott SL. Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS ONE 2011;6:e27310.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001;25:402-8.
24. R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. http://wwwR-projectorg/
25. Anderson MJ. A new method for non-parametric multivariate analysis of variance. Austral Ecol 2001;26:32-46.
26. Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 2005;71:8228-35.
27. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 1995;57:289-300.
28. Dejea CM, Wick EC, Hechenbleikner EM, et al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc Natl Acad Sci USA 2014;111:18321-6.
29. Geng J, Song Q, Tang X, et al. Co-occurrence of driver and passenger bacteria in human colorectal cancer. Gut Pathog 2014;6:26.
30. Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature 2011;473:174-80.
31. Acharyya S, Oskarsson T, Vanharanta S, et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 2012;150:165-78.
32. Wang D, Wang H, Brown J, et al. CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med 2006;203:941-51.
33. Grivennikov SI, Wang K, Mucida D, et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012;491:254-8.
34. Warren RL, Freeman DJ, Pleasance S. Co-occurrence of anaerobic bacteria in colorectal carcinomas. Microbiome 2013;1:16.
35. Ghadjar P, Rubie C, Aebersold DM, et al. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. Int J Cancer 2009;125:741-5.
36. Shanahan F, O'Toole PW. Host-microbe interactions and spatial variation of cancer in the gut. Nat Rev Cancer 2014;14:511-12.
37. Jalanka J, Salonen A, Salojärvi J, et al. Effects of bowel cleansing on the intestinal microbiota. Gut 2014.